This study will test the effectiveness of lisdexamfetamine medication as a treatment for loss-of-control eating and weight following bariatric surgery. This is a controlled test of whether, amongst non-responders to acute treatments, lisdexamfetamine medication results in superior outcomes compared with placebo.
Age range
18 Years – 64 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Loss-of-Control Eating Frequency
Timeframe: From baseline interview at study enrollment to after the 12-week treatment
Loss-of-Control Eating Frequency
Timeframe: From post-treatment to the 6-month follow-up
Loss-of-Control Eating Frequency
Timeframe: From post-treatment to the 12-month follow-up
Body Mass Index (BMI)
Timeframe: From baseline at study enrollment to after the 12-week treatment
Body Mass Index (BMI)
Timeframe: From post-treatment to the 6-month follow-up
Body Mass Index (BMI)
Timeframe: From post-treatment to the 12-month follow-up